STAA Q2 2018 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$871M

Q2 2018 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$34M+54.6% YoY

Gross Profit

$25M74.4% margin

Operating Income

$3M8.9% margin

Net Income

$2M5.4% margin

EPS (Diluted)

$0.04

QoQ Revenue Growth

+25.1%

Cash Flow

Operating Cash Flow

-$224,000

Free Cash Flow

-$528,000

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$83M

Total Liabilities

$32M

Stockholders' Equity

$51M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$34M	$22M	+54.6%
Gross Profit	$25M	$15M	+63.0%
Operating Income	$3M	-$1M	+329.2%
Net Income	$2M	-$971,000	+288.5%

Revenue Segments

Implantable Collamer Lenses

$27M80%

Intraocular Lenses

$4M12%

Other Surgical Products

$2M7%

Geographic Segments

CHINA

$14M41%

Other Countries

$13M39%

JAPAN

$7M20%